RKDA
Arcadia Biosciences·NASDAQ
--
--(--)
--
--(--)
7.92 / 10
Outperform
Fund‑flow sentiment is strong (7.92/10, good), with block and extra‑large investors netting inflows, though overall and other size categories trend negative. Analyst coverage is absent, leaving the market’s expectations driven mainly by liquidity patterns.
Fund Flow Rating
Is money flowing into or out of RKDA?
- RKDA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.92/10 (Outperform).
